Oppositely, it was found that FGP and SGP intervention significantly inhibited the expression levels of TLR4, MyD88, p‐P65/P65, p‐IκBα/IκBα, and p‐NF‐κB/NF‐κB, suggesting that FGP and SGP attenuated CTX‐induced liver inflammation (Figure 5B). This evidence concerns the gene MYD88 and Hepatitis.